GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BAT-2094 | batifiban | Beitaning | Betagrin® | Compound I [CN101085809A]
bevifibatide is an approved drug
Compound class:
Peptide
Comment: Bevifibatide (Bio-Thera Solutions) is a synthetic cyclic heptapeptide that functions as a αIIbβ3 and αvβ3 integrin receptor antagonist [2]. It was designed to inhibit platelet aggregation as an antiplatelet cardiovascular therapy.
|
|
|||||||||||||||||
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. China NMPA (2024) |
Synonyms ![]() |
| BAT-2094 | batifiban | Beitaning | Betagrin® | Compound I [CN101085809A] |
Database Links ![]() |
|
| CAS Registry No. | 710312-77-9 (source: PubChem) |
| GtoPdb PubChem SID | 513757638 |
| PubChem CID | 71556891 |
| Search Google for chemical match using the InChIKey | UUQHAAWMCLITRZ-KEOOTSPTSA-N |
| Search Google for chemicals with the same backbone | UUQHAAWMCLITRZ |
| UniChem Compound Search for chemical match using the InChIKey | UUQHAAWMCLITRZ-KEOOTSPTSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | UUQHAAWMCLITRZ-KEOOTSPTSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Batifiban (links to external site)
Cat. No. HY-125053 |